人工智能与机器学习在核医学中的未来展望
本文综述了人工智能与机器学习在核医学影像中的应用趋势,涵盖肿瘤全身显像、心脏灌注显像、神经退行性疾病影像及技术性应用(如衰减校正、图像重建和超低剂量PET去噪)。目前多数方法仍处于早期开发阶段,需进一步改进才能广泛临床应用。
要点
- AI可用于肿瘤PET/骨显像的全身肿瘤体积量化、病灶分割分类及微转移诊断。
- 心脏灌注显像的自动特征选择、分割和分类有助于识别获益于干预的患者并预测预后。
- AI衰减校正可避免配准CT扫描,超低剂量PET去噪可能拓展肿瘤PET筛查应用。
核心结论
- AI与机器学习在核医学影像多领域有应用前景,但多数方法仍处早期开发阶段,需进一步改进才能广泛临床应用。
研究设计与样本
- 综述类文章,检索范围未明确报告,聚焦肿瘤全身显像、心脏影像、神经影像及技术趋势四个领域。
主要发现
- 肿瘤显像中AI可用于全身肿瘤体积量化、病理灶分割分类及微转移诊断,并可关联影像特征与总生存等临床终点。
- 良性病变显像中AI主要用于自动或辅助图像分类与临床决策,如心肌灌注显像自动特征选择、分割和分类。
- 神经退行性疾病(如阿尔茨海默病)的自动报告可能扩展至早期诊断,尤其在靶向治疗可选时更具意义。
- 技术性应用包括AI衰减校正(避免配准CT)、图像重建(减少伪影)及超低剂量PET去噪。
临床怎么用
- AI可用于辅助肿瘤PET/骨显像的全身肿瘤体积量化和病灶分割分类。
- 心脏灌注显像的AI自动分析可辅助识别获益于干预的患者并预测预后。
- AI衰减校正可减少对配准CT的需求,超低剂量PET去噪可能拓展肿瘤PET筛查适用性。
局限性
- 多数AI方法仍处早期开发阶段,需进一步改进才能广泛临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence and machine learning based approaches are increasingly finding their way into various areas of nuclear medicine imaging. With the technical development of new methods and the expansion to new fields of application, this trend is likely to become even more pronounced in future. Possible means of application range from automated image reading and classification to correlation with clinical outcomes and to technological applications in image processing and reconstruction. In the context of tumor imaging, that is, predominantly FDG or PSMA PET imaging but also bone scintigraphy, artificial intelligence approaches can be used to quantify the whole-body tumor volume, for the segmentation and classification of pathological foci or to facilitate the diagnosis of micro-metastases. More advanced applications aim at the correlation of image features that are derived by artificial intelligence with clinical endpoints, for example, whole-body tumor volume with overall survival. In nuclear medicine imaging of benign diseases, artificial intelligence methods are predominantly used for automated and/or facilitated image classification and clinical decision making. Automated feature selection, segmentation and classification of myocardial perfusion scintigraphy can help in identifying patients that would benefit from intervention and to forecast clinical prognosis. Automated reporting of neurodegenerative diseases such as Alzheimer's disease might be extended to early diagnosis-being of special interest, if targeted treatment options might become available. Technological approaches include artificial intelligence-based attenuation correction of PET images, image reconstruction or anatomical landmarking. Attenuation correction is of special interest for avoiding the need of a coregistered CT scan, in the process of image reconstruction artefacts might be reduced, or ultra low-dose PET images might be denoised. The development of accurate ultra low-dose PET imaging might broaden the method's applicability, for example, toward oncologic PET screening. Most artificial intelligence approaches in nuclear medicine imaging are still in early stages of development, further improvements are necessary for broad clinical applications. In this review, we describe the current trends in the context fields of body oncology, cardiac imaging, and neuroimaging while an additional section puts emphasis on technological trends. Our aim is not only to describe currently available methods, but also to place a special focus on the description of possible future developments.
引用
- Seifert R, Weber M, Kocakavuk E, et al. Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives. Semin Nucl Med. 2020. PMID: 33509373. doi:10.1053/j.semnuclmed.2020.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。